Bulletin
Investor Alert

Company Close Updates

May 18, 2022, 4:31 p.m. EDT

Moderna Inc. stock falls Wednesday, still outperforms market

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) shed 3.21% to $137.71 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) falling 4.73% to 11,418.15 and Dow Jones Industrial Average (DOW:DJIA) falling 3.57% to 31,490.07. Moderna Inc. closed $359.78 short of its 52-week high ($497.49), which the company achieved on August 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. (NYS:ABBV) fell 1.52% to $152.43, Amgen Inc. (NAS:AMGN) fell 0.57% to $243.96, and AstraZeneca PLC ADR (NAS:AZN) fell 3.53% to $63.32. Trading volume (5.0 M) remained 2.2 million below its 50-day average volume of 7.2 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.